Summary & Headlines:

We're back with updates in the digital health world! Read about more highlights here:

‍

Disease Management / Digital Therapeutics

Daiichi Sankyo partnered with GAIA AG to commercialize a prescription DTx for hypercholesterolemia, signaling pharma’s growing interest in integrating software into treatment pathways. Meanwhile, Cognito Therapeutics raised $105M to advance a device-based Alzheimer’s therapy, highlighting a shift toward hardware-enabled, at-home digital therapeutics that compete more directly with traditional drugs.

‍

Informatics / Healthcare IT Solutions

Perplexity AI launched an AI-powered health assistant that aggregates multimodal data to deliver personalized insights, positioning LLMs as the primary interface for navigating health information. Google partnered with DocMorris to build an end-to-end AI health platform, signaling a shift toward integrated, AI-native care delivery models spanning diagnosis through fulfillment.

‍

Women’s Health / Femtech

WHOOP expanded into hormone-based biomarker testing, integrating women’s health diagnostics into its wearable platform and reinforcing the convergence of femtech and digital health. May Health raised $11.7M to advance a device-based PCOS infertility treatment, highlighting the growing trend toward combining clinical interventions with digital monitoring and support.

‍

Healthy Aging / Longevity

Hone Health partnered with BodySpec to integrate clinical-grade diagnostics into its platform, advancing a hybrid model of telehealth, imaging, and personalized care. Loovi raised $1M to scale a data-driven preventive health platform, underscoring the shift toward continuous, AI-enabled health optimization.

‍

Digital Therapeutics

1 | Daiichi Sankyo pens pact with Germany's Gaia to sell digital therapeutic for high cholesterol

Daiichi Sankyo partnered with GAIA to commercialize a prescription digital therapeutic for hypercholesterolemia, signaling pharma’s interest in integrating software and patient care. The product delivers CBT-based behavioral interventions to improve lifestyle adherence alongside drug therapy, reinforcing digital health’s role in addressing gaps pharmacology alone cannot solve. Its planned use within Germany’s DiGA reimbursement pathway highlights the importance of regulated, prescribable frameworks for digital therapeutics’ scalability. Overall, the partnership reflects a shift from experimental pilots to commercially integrated “drug plus digital” models in chronic disease management.

‍

2 | Cognito Therapeutics announces oversubscribed $105M Series C financing to advance Spectris in Alzheimer’s disease

Cognito Therapeutics raised $105M to advance Spectris, a non-invasive neurostimulation therapy for Alzheimer’s disease designed for at-home use. The platform uses light and sound stimulation to modulate brain activity, positioning it as a device-enabled digital therapeutic rather than a software-only solution. Its prescription-based, home-use model reflects the broader shift toward remote delivery of clinically validated therapies. Importantly, this approach moves digital health into disease-modifying treatment territory, competing more directly with traditional pharmaceuticals.

‍

‍

Healthcare / IT Solutions

1 | Perplexity launches Perplexity Health

Perplexity AI launched Perplexity Health, an AI-powered assistant that aggregates data from wearables, labs, and medical records to provide personalized health insights. The product positions AI as the primary interface for navigating and interpreting health data, rather than relying on fragmented apps or portals. By synthesizing multimodal inputs into conversational outputs, it addresses one of digital health’s core challenges: data fragmentation and lack of usability. This signals a broader shift toward health copilots that may increasingly influence patient decision-making and care navigation.

‍

2 | Google partners with DocMorris on AI health platform for Europe

Google partnered with DocMorris to develop an AI-powered digital health platform spanning symptom checking, prescribing, and pharmacy fulfillment. The initiative integrates conversational AI with medication access, creating a more seamless end-to-end patient journey. By embedding AI across both care navigation and commerce, the model reflects a shift toward AI-native healthcare delivery platforms. Strategically, the partnership underscores Big Tech’s move to scale in healthcare through collaboration with regulated incumbents rather than direct disruption.

‍

‍

Women’s Health / Femtech

1 | WHOOP broadens WHOOP Advanced Labs offering, announcing a women’s health specialized blood biomarker panel

WHOOP expanded its Advanced Labs offering to include comprehensive blood biomarker testing for women’s health hormone panels in its wearable platform. This move extends WHOOP from passive tracking into hybrid diagnostics, combining continuous sensor data with longitudinal insights, particularly for areas like menstrual health and hormonal balance. The platform uses AI to translate multimodal data into personalized recommendations, reinforcing a shift toward actionable, individualized health optimization. Strategically, it highlights the growing convergence of femtech and digital health, where consumer platforms are evolving into clinically relevant tools for monitoring and managing women’s health over time.

‍

2 | May Health raises $11.7M to advance its novel technology to treat PCOS-related infertility

May Health raised ~$11.7M to advance a device-based solution for PCOS-related infertility, integrating procedural intervention with digital monitoring. This reflects a shift toward procedure plus digital follow-up models in reproductive health. The approach aligns with broader trends of combining clinical intervention with longitudinal digital tracking and support.

‍

‍

Longevity / Healthy Aging

1 | Hone Health integrates BodySpec DEXA scans to expand its personalized longevity OS

Hone Health partnered with BodySpec to integrate clinical-grade DEXA body composition scans into its digital longevity platform. This enables physicians to combine imaging data with hormone and metabolic insights to deliver more personalized and precise care plans. The integration expands the platform from telehealth into a hybrid model that incorporates diagnostics and longitudinal monitoring. Strategically, it highlights the convergence of diagnostics and digital care, reinforcing a shift toward measurement-driven, continuously managed health.

‍

2 | Stockholm-based Loovi secures $1M to scale preventive health and longevity platform

Loovi raised $1M to scale a digital platform focused on preventive health and longevity, aiming to help users proactively manage their long-term health. The platform aggregates health data and provides longitudinal insights to guide behavior and lifestyle decisions over time. This reflects a broader shift in digital health toward continuous, data-driven prevention rather than episodic care. Loovi represents the growing category of health optimization platforms where AI-driven insights and personalized recommendations are central to value creation.